Work

Acute liver injury in a Glatopa-treated patient with MS

Year: 2017

Type: article

Abstract: Hepatotoxicity is rarely associated with glatiramer acetate (GA) treatment of relapsing MS. Here, we report a case of acute liver injury associated with generic GA (Glatopa, manufactured by Sandoz, a Novartis company, Holzkirchen, Upper Bavaria, Germany). Acknowledgment: The authors are grateful for Collin Spencer's help in preparing the figure.

Source: Neurology Neuroimmunology & Neuroinflammation

DOI: 10.1212/nxi.0000000000000368

Authors: Joseph J. Sabatino, Neil J. Mehta, Sanjay Kakar, Scott S. Zamvil, Bruce A.C. Cree

Institution: University of California, San Francisco

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,450